V3GU.L vs. BPCR.L
Compare and contrast key facts about Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L) and BioPharma Credit plc (BPCR.L).
V3GU.L is a passively managed fund by Vanguard that tracks the performance of the Bloomberg Gbl Agg Corp 0901 TR Hdg USD. It was launched on May 20, 2021.
Performance
V3GU.L vs. BPCR.L - Performance Comparison
Loading graphics...
V3GU.L vs. BPCR.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
V3GU.L Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating | -0.53% | 6.28% | 3.97% | 8.61% | -13.25% | -0.93% |
BPCR.L BioPharma Credit plc | 7.38% | 19.78% | 22.20% | 2.59% | 13.30% | 3.04% |
Returns By Period
In the year-to-date period, V3GU.L achieves a -0.53% return, which is significantly lower than BPCR.L's 7.38% return.
V3GU.L
- 1D
- 0.41%
- 1M
- -1.38%
- YTD
- -0.53%
- 6M
- 0.29%
- 1Y
- 4.30%
- 3Y*
- 5.24%
- 5Y*
- —
- 10Y*
- —
BPCR.L
- 1D
- 0.86%
- 1M
- -0.21%
- YTD
- 7.38%
- 6M
- 7.15%
- 1Y
- 22.65%
- 3Y*
- 15.34%
- 5Y*
- 14.37%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
V3GU.L vs. BPCR.L — Risk / Return Rank
V3GU.L
BPCR.L
V3GU.L vs. BPCR.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L) and BioPharma Credit plc (BPCR.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| V3GU.L | BPCR.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.94 | 1.58 | -0.64 |
Sortino ratioReturn per unit of downside risk | 1.33 | 2.36 | -1.02 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.31 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 1.53 | 2.94 | -1.40 |
Martin ratioReturn relative to average drawdown | 6.30 | 11.66 | -5.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| V3GU.L | BPCR.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.94 | 1.58 | -0.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.14 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | 0.95 | -0.85 |
Correlation
The correlation between V3GU.L and BPCR.L is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
V3GU.L vs. BPCR.L - Dividend Comparison
V3GU.L has not paid dividends to shareholders, while BPCR.L's dividend yield for the trailing twelve months is around 14.18%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
V3GU.L Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BPCR.L BioPharma Credit plc | 14.18% | 13.78% | 14.99% | 15.79% | 14.30% | 10.39% | 10.73% | 8.96% | 10.10% | 2.56% |
Drawdowns
V3GU.L vs. BPCR.L - Drawdown Comparison
The maximum V3GU.L drawdown since its inception was -18.89%, which is greater than BPCR.L's maximum drawdown of -14.00%. Use the drawdown chart below to compare losses from any high point for V3GU.L and BPCR.L.
Loading graphics...
Drawdown Indicators
| V3GU.L | BPCR.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.89% | -14.00% | -4.89% |
Max Drawdown (1Y)Largest decline over 1 year | -2.85% | -7.80% | +4.95% |
Max Drawdown (5Y)Largest decline over 5 years | — | -13.92% | — |
Current DrawdownCurrent decline from peak | -1.71% | -0.84% | -0.87% |
Average DrawdownAverage peak-to-trough decline | -7.03% | -2.53% | -4.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.70% | 1.97% | -1.27% |
Volatility
V3GU.L vs. BPCR.L - Volatility Comparison
The current volatility for Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L) is 1.89%, while BioPharma Credit plc (BPCR.L) has a volatility of 4.61%. This indicates that V3GU.L experiences smaller price fluctuations and is considered to be less risky than BPCR.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| V3GU.L | BPCR.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.89% | 4.61% | -2.72% |
Volatility (6M)Calculated over the trailing 6-month period | 2.66% | 9.74% | -7.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 4.55% | 14.25% | -9.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 6.19% | 12.58% | -6.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 6.19% | 11.89% | -5.70% |